Evaluate the Safety and Efficacy of STSG-0002 Injection in Patients With Chronic Hepatitis B
Clinical trial NCT05760703 · TERMINATED
Trial details
- NCT number
- NCT05760703
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-25
- Primary completion
- 2023-12-11
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.